These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1808341)

  • 1. [Novel active analogues of vitamin D3 for therapy of secondary hyperparathyroidism due to long-term hemodialysis in patients with chronic kidney failure].
    Kobayashi T; Nishii Y
    Nihon Rinsho; 1991 Dec; 49 Suppl():715-9. PubMed ID: 1808341
    [No Abstract]   [Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Falecalcitriol as a new therapeutic agent for secondary hyperparathyroidism].
    Morii H
    Clin Calcium; 2005 Jan; 15(1):29-33. PubMed ID: 15632470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term suppressive effect of falecalcitriol on parathyroid hormone secretion in secondary hyperparathyroidism in hemodialysis patients].
    Iwao Y; Yamaguchi Y; Fujii K; Toba Y; Asada M; Nagano N; Yamamoto H; Hyoma K; Yamada S; Hirano H; Tone Y; Ohtani H; Saika Y; Fujii R
    Clin Calcium; 2006 May; 16(5):847-51. PubMed ID: 16679628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin D "pulse" therapy for secondary hyperparathyroidism due to long-term hemodialysis in patients with chronic kidney failure].
    Akiba T
    Nihon Rinsho; 1991 Dec; 49 Suppl():720-4. PubMed ID: 1808342
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advantage of intravenous pulse therapy with calcitriol or maxacalcitol in dialysis patients with renal hyperparathyroidism].
    Yumita S
    Clin Calcium; 2004 Sep; 14(9):69-72. PubMed ID: 15577114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D
    Pandey R; Zella JB; Zhu JG; Plum LA; Clagett-Dame M; Blaser WJ; Bedale W; DeLuca HF; Coyne DW
    Drugs R D; 2017 Dec; 17(4):597-605. PubMed ID: 28905271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality risk among hemodialysis patients receiving different vitamin D analogs.
    Tentori F; Hunt WC; Stidley CA; Rohrscheib MR; Bedrick EJ; Meyer KB; Johnson HK; Zager PG;
    Kidney Int; 2006 Nov; 70(10):1858-65. PubMed ID: 17021609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients.
    Saha H; Pietilä K; Mustonen J; Pasternack A; Mörsky P
    Clin Nephrol; 1992 Sep; 38(3):145-8. PubMed ID: 1395167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral vitamin D3 pulse therapy for overt secondary hyperparathyroidism at pre-dialysis stage.
    Watanabe Y; Inaguma D; Fukuzawa Y; Kumon S; Yamazaki C
    Nephrol Dial Transplant; 1996 May; 11(5):910-1. PubMed ID: 8671931
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival differences between activated injectable vitamin D2 and D3 analogs.
    Kalantar-Zadeh K
    Kidney Int; 2007 Apr; 71(8):827; author reply 827-8. PubMed ID: 17429422
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism.
    Slatopolsky E; Berkoben M; Kelber J; Brown A; Delmez J
    Kidney Int Suppl; 1992 Oct; 38():S43-9. PubMed ID: 1405381
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
    Akiba T; Marumo F; Owada A; Kurihara S; Inoue A; Chida Y; Ando R; Shinoda T; Ishida Y; Ohashi Y
    Am J Kidney Dis; 1998 Aug; 32(2):238-46. PubMed ID: 9708607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion from intravenous maxacalcitol to oral vitamin D in secondary hyperparathyroidism management.
    Tanemoto M; Katsuoka Y
    Clin Exp Nephrol; 2022 Jan; 26(1):97-98. PubMed ID: 34549338
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of secondary hyperparathyroidism: the gap between diagnosis and treatment. The Renal Osteodystrophy Multicenter Enquiry.
    Díaz-Corte C; Cannata-Andía JB
    Am J Med Sci; 2000 Aug; 320(2):107-11. PubMed ID: 10981485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotherapy of high-dose 1,25-dihydroxyvitamin D3 in hemodialysis patients with secondary hyperparathyroidism: a single-dose study.
    Tsuruoka S; Sugimoto K; Ohmori M; Kawaguchi A; Saito T; Fujimura A
    Clin Pharmacol Ther; 1999 Dec; 66(6):609-16. PubMed ID: 10613617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
    Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB
    Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.